Maggiore Q, Zoccali C, Monzani G, Contini C
Nephron. 1978;22(4-6):391-8. doi: 10.1159/000181481.
The hemodynamic mechanism of the hypotensive effect of propranolol was studied by quantitative radiocardiography in 8 patients with dialysis-resistant hypertension. Propranolol treatment brought about a decrease in mean arterial pressure and peripheral vascular resistances. The cardiac index was slightly reduced only in the early stage of the treatment. No significant difference was found between patients on treatments lasting longer than 3 months and patients with dialysis-controlled hypertension. The results show that propranolol can be used safely as the sole antihypertensive agent in patients with dialysis-resistant hypertension.
采用定量放射性心动图对8例透析抵抗性高血压患者进行研究,以探讨普萘洛尔降压作用的血流动力学机制。普萘洛尔治疗可使平均动脉压和外周血管阻力降低。仅在治疗早期心脏指数略有降低。治疗时间超过3个月的患者与透析控制良好的高血压患者之间未发现显著差异。结果表明,普萘洛尔可作为透析抵抗性高血压患者的唯一降压药物安全使用。